000 01237 a2200337 4500
005 20250517184840.0
264 0 _c20181221
008 201812s 0 0 eng d
022 _a1744-7593
024 7 _a10.1080/17425247.2018.1406917
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKourmatzis, A
245 0 0 _aAirway geometry, airway flow, and particle measurement methods: implications on pulmonary drug delivery.
_h[electronic resource]
260 _bExpert opinion on drug delivery
_c03 2018
300 _a271-282 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Inhalation
650 0 4 _aAerosols
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
650 0 4 _aDry Powder Inhalers
650 0 4 _aForced Expiratory Flow Rates
650 0 4 _aHumans
650 0 4 _aLung
_xdrug effects
650 0 4 _aParticle Size
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdrug therapy
650 0 4 _aRespiratory Function Tests
700 1 _aCheng, S
700 1 _aChan, H-K
773 0 _tExpert opinion on drug delivery
_gvol. 15
_gno. 3
_gp. 271-282
856 4 0 _uhttps://doi.org/10.1080/17425247.2018.1406917
_zAvailable from publisher's website
999 _c27798972
_d27798972